Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Brain Research

• Publication date

  1995-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-8993(95)00614-VPMID 8535839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developmentally regulated glycosylation of dopamine transporter.

  1994cited by this paper
• Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self- administration

  1994cited by this paper
• Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral function.

  1994cited by this paper
• Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.

  1994cited by this paper
• Subtypes of Sodium‐Dependent High‐Affinity L‐[3H]Glutamate Transport Activity: Pharmacologic Specificity and Regulation by Sodium and Potassium

  1993cited by this paper
• Cocaine-sensitive and -insensitive dopamine uptake in prefrontal cortex, nucleus accumbens and striatum.

  1993cited by this paper
• Neurotransmitter transporters: three distinct gene families.

  1993cited by this paper
• Neurotransmitter transporters: recent progress.

  1993cited by this paper
• Molecular characterization of the dopamine transporter.

  1993cited by this paper
• Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens.

  1992cited by this paper
• Expression of a single dopamine transporter cDNA can confer two cocaine binding sites

  1992cited by this paper
• In vivo binding of [125I] RTI‐55 to dopamine transporters: Pharmacology and regional distribution with autoradiography

  1992cited by this paper
• Dopamine transporter imaging with novel, selective cocaine analogs.

  1992cited by this paper
• Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI‐55

  1992cited by this paper
• Isopropyl and phenyl esters of 3 beta-(4-substituted phenyl)tropan-2 beta-carboxylic acids. Potent and selective compounds for the dopamine transporter.

  1992cited by this paper
• High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain

  1992cited by this paper
• [125I]RTI-55: a potent ligand for dopamine transporters.

  1991cited by this paper
• Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter

  1991cited by this paper
• Cloning and expression of a functional serotonin transporter from rat brain

  1991cited by this paper
• Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.

  1991cited by this paper
• Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

  1991cited by this paper
• Cloning of the cocaine-sensitive bovine dopamine transporter.

  1991cited by this paper
• The dopamine hypothesis of the reinforcing properties of cocaine.

  1991cited by this paper
• In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.

  1991cited by this paper
• A rapid binding assay for solubilized dopamine transporters using [3H]WIN 35,428.

  1991cited by this paper
• Pharmacologically distinct sodium-dependent L-[3H]glutamate transport processes in rat brain.

  1991cited by this paper
• Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights

  1991cited by this paper
• Synthesis and ligand binding of cocaine isomers at the cocaine receptor.

  1991cited by this paper
• Dopamine transporter: deglycosylation with exo- and endoglycosidases.

  1991cited by this paper
• Cloning of a serotonin transporter affected by antidepressants.

  1991cited by this paper
• Tritium quench in autoradiography during postnatal development of rat forebrain.

  1990cited by this paper
• Dopamine uptake: a review of progress in the last decade.

  1990cited by this paper
• Cloning and expression of a rat brain GABA transporter.

  1990cited by this paper
• [3H]WIN 35,065–2: A Ligand for Cocaine Receptors in Striatum

  1990cited by this paper
• Dopamine transporter: biochemistry, pharmacology and imaging.

  1990cited by this paper
• Cocaine receptors: In vivo labeling with 3H‐(—)cocaine, 3H‐win 35,065‐2, and 3H‐win 35,428

  1989cited by this paper
• Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.

  1989cited by this paper
• Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.

  1989cited by this paper
• Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.

  1988cited by this paper
• [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex.

  1988cited by this paper
• The Affective Disorders

  1987cited by this paper
• Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

  1987cited by this paper
• Quantitative autoradiographic localization of the dopamine transport complex in the rat brain: use of a highly selective radioligand: [3H]GBR 12935.

  1986cited by this paper
• Characterization of Sodium‐Dependent [3H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport Complex

  1986cited by this paper
• Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain

  1986cited by this paper
• Heterogeneity of sodium‐dependent excitatory amino uptake mechanisms in rat brain

  1986cited by this paper
• Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.

  1985cited by this paper
• [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.

  1984cited by this paper
• Neurotransmitter Receptor Binding

  1984cited by this paper
• Mammalian beta-adrenergic receptors. Distinct glycoprotein populations containing high mannose or complex type carbohydrate chains.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Action of drugs of abuse on brain reward systems.

  1980cited by this paper
• Central catecholamine neuron systems: anatomy and physiology of the dopamine systems.

  1978cited by this paper

• Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.

  2019cites this paper
• Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report

  2019cites this paper
• Effects of Maturation on Striatal Dopamine Transporter Availability in Rats

  2019cites this paper
• Perinatal MAO Inhibition Produces Long-Lasting Impairment of Serotonin Function in Offspring

  2018cites this paper
• Regional differences in dopamine release in the R6/2 mouse caudate putamen.

  2018cites this paper
• Improving the management of Parkinson's disease : the experience of hospitalisation and a novel MRI-based diagnostic tool

  2017cites this paper
• Locus Coeruleus and Dopamine-Dependent Memory Consolidation

  2017cites this paper
• Effects of diet and insulin on dopamine transporter activity and expression in rat caudate‐putamen, nucleus accumbens, and midbrain

  2017cites this paper
• Caractérisation de la transmission GABAergique dans le globus pallidus externe chez des modèles rongeurs des maladies de Parkinson et de Huntington

  2015cites this paper
• Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.

  2014cites this paper
• Non-dioxin-like PCBs inhibit [(3)H]WIN-35,428 binding to the dopamine transporter: a structure-activity relationship study.

  2013cites this paper
• The Hippocampal-VTA Loop: The Role of Novelty and Motivation in Controlling the Entry of Information into Long-Term Memory

  2013cites this paper
• Alterations in the striatal dopamine system during intravenous methamphetamine exposure: Effects of contingent and noncontingent administration

  2013cites this paper
• Intrinsically Motivated Learning in Natural and Artificial Systems

  2013cites this paper
• In silico tools in risk assessment : of industrial chemicals in general and non-dioxin-like PCBs in particular

  2012cites this paper
• Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB‐1020: Implications for treatment of attention‐deficit hyperactivity disorder

  2012cites this paper
• An investigation of neurochemical, structural and functional characteristics in the murine model of collagen induced arthritis

  2011cites this paper
• Modulation of the activity of globus pallidus by dopamine D1-like receptors in parkinsonian rats.

  2011cites this paper
• Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.

  2011cites this paper
• Extrastriatal Dopaminergic Circuits of the Basal Ganglia

  2010cites this paper
• Lack of effect of dopaminergic denervation on caudate-putamen hyperthermia or hypothermia induced by drugs and mild stressors.

  2010cites this paper
• Variations in catechol-O-methyltransferase gene interact with parenting to influence attention in early development.

  2009cites this paper
• Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast.

  2009cites this paper
• Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.

  2006cites this paper
• Behavioral and Brain Functions

  2006cites this paper
• [11C]SMe-ADAM, an imaging agent for the brain serotonin transporter: synthesis, pharmacological characterization and microPET studies in rats.

  2006cites this paper
• Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization

  2005cites this paper
• Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

  2005cites this paper
• Neuroimaging in Parkinson’s Disease

  2005cites this paper
• Non–stimulant medications in the treatment of ADHD

  2004cites this paper
• Segregation of Amphetamine Reward and Locomotor Stimulation between Nucleus Accumbens Medial Shell and Core

  2003cites this paper
• Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease.

  2003cites this paper
• Schizophrenia and Bipolar Disorder as Putative Dopamine-Linked Illnesses

  2003cites this paper
• Imaging Dopamine Transporters in Parkinson’s Disease and Other Movement Disorders

  2003cites this paper
• SegregationofAmphetamineRewardandLocomotor StimulationbetweenNucleusAccumbensMedialShelland Core

  2003cites this paper
• The Serotonin Transporter is Required for Stress-Evoked Increases in Adrenal Catecholamine Synthesis and Angiotensin II AT2 Receptor Expression

  2003influential citation
• Autoradiographic imaging of the serotonin transporter in the brain of rats and pigs using S-([18F]fluoromethyl)-(+)-McN5652.

  2003cites this paper
• Age-related differences in MK-801- and amphetamine-induced locomotor and stereotypic activities of rats.

  2003cites this paper
• Evidence for Sequence-Dependent and Reversible Nonspecific Effects of PS-Capped Antisense Treatment After Intracerebral Administration

  2002influential citation
• [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents.

  2002cites this paper
• Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study.

  2002cites this paper
• Release and uptake of catecholamines in the bed nucleus of the stria terminalis measured in the mouse brain slice

  2002influential citation
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

  2002cites this paper
• Brief Communication Evidence for Sequence-Dependent and Reversible Nonspecific Effects of PS-Capped Antisense Treatment After Intracerebral Administration

  2002cites this paper
• Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats.

  2001cites this paper
• Localization of dopaminergic markers in the human subthalamic nucleus

  2000cites this paper
• Tyrosine hydroxylase‐immunoreactive elements in the human globus pallidus and subthalamic nucleus

  1999cites this paper
• Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.

  1999cites this paper
• Pharmacological Characterization of (E)-N-(3-iodoprop-2-enyl)-2β-Carbomethoxy-3β-(4′-methylphenyl)nortropane as a Selective and Potent Inhibitor of the Neuronal Dopamine Transporter

  1999cites this paper
• Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat

  1999cites this paper
• Non‐amine dopamine transporter probe [3H]tropoxene distributes to dopamine‐rich regions of monkey brain

  1999cites this paper
• Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter

  1998cites this paper
• Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.

  1998cites this paper
• Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation.

  1998cites this paper
• In Vivo Electrochemical Studies of Dopamine Clearance in the Rat Substantia Nigra: Effects of Locally Applied Uptake Inhibitors and Unilateral 6‐Hydroxydopamine Lesions

  1998cites this paper
• Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.

  1998cites this paper
• Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats.

  1998cites this paper
• Striatal [125I]RTI-55 binding sites in cocaine-abusing humans

  1998cites this paper
• Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2beta-propanoyl-3beta-(2-Naphthyl)-tropane.

  1998cites this paper
• Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428.

  1997cites this paper
• Postnatal development of the dopamine transporter: a quantitative autoradiographic study.

  1996cites this paper
• 6-Hydroxydopamine-mediated induction of rat brain metallothionein I mRNA.

  1996cites this paper